Penn Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$13.7M	Sell	120,384 -455	-0.4%	-$51.8K	1.18%	41
2025 Q1	$12.7M	Buy	120,839 +16,409	+16%	+$1.73M	1.24%	37
2024 Q4	$11.2M	Buy	104,430 +4,212	+4%	+$451K	1.1%	45
2024 Q3	$10M	Buy	+100,218	New	+$10M	0.92%	51